Osteocyte-Mediated Translation of Mechanical Stimuli to Cellular Signaling and Its Role in Bone and Non-bone-Related Clinical Complications.

Abstract:

PURPOSE OF REVIEW:Osteocytes comprise > 95% of the cellular component in bone tissue and produce a wide range of cytokines and cellular signaling molecules in response to mechanical stimuli. In this review, we aimed to summarize the molecular mechanisms involved in the osteocyte-mediated translation of mechanical stimuli to cellular signaling, and discuss their role in skeletal (bone) diseases and extra-skeletal (non-bone) clinical complications. RECENT FINDINGS:Two decades before, osteocytes were assumed as a dormant cells buried in bone matrix. In recent years, emerging evidences have shown that osteocytes are pivotal not only for bone homeostasis but also for vital organ functions such as muscle, kidney, and heart. Osteocyte mechanotransduction regulates osteoblast and osteoclast function and maintains bone homeostasis. Mechanical stimuli modulate the release of osteocyte-derived cytokines, signaling molecules, and extracellular cellular vesicles that regulate not only the surrounding bone cell function and bone homeostasis but also the distant organ function in a paracrine and endocrine fashion. Mechanical loading and unloading modulate the osteocytic release of NO, PGE2, and ATPs that regulates multiple cellular signaling such as Wnt/β-catenin, RANKL/OPG, BMPs, PTH, IGF1, VEGF, sclerostin, and others. Therefore, the in-depth study of the molecular mechanism of osteocyte mechanotransduction could unravel therapeutic targets for various bone and non-bone-related clinical complications such as osteoporosis, sarcopenia, and cancer metastasis to bone.

journal_name

Curr Osteoporos Rep

authors

Yan Y,Wang L,Ge L,Pathak JL

doi

10.1007/s11914-020-00564-9

subject

Has Abstract

pub_date

2020-02-01 00:00:00

pages

67-80

issue

1

eissn

1544-1873

issn

1544-2241

pii

10.1007/s11914-020-00564-9

journal_volume

18

pub_type

杂志文章,评审
  • MicroRNA Exert Macro Effects on Cancer Bone Metastasis.

    abstract::Bone metastasis is a deadly complication of cancers arising from many different primary tumor locations. Cross talk between cancer and bone cells is a well-established driver of bone metastasis, and recent work reveals microRNA (miRNA) as key players in this communication. Functional significance of miRNA was first de...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-016-0316-1

    authors: Baier SR,Wan Y

    更新日期:2016-10-01 00:00:00

  • Bone cells and bone turnover in diabetes mellitus.

    abstract::Substantial evidence exists that in addition to the well-known complications of diabetes, increased fracture risk is an important morbidity. This risk is probably due, at least in part, to altered bone remodeling and bone cell function in diabetes. Circulating biochemical markers of bone formation, including P1NP, ost...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章

    doi:10.1007/s11914-015-0265-0

    authors: Rubin MR

    更新日期:2015-06-01 00:00:00

  • Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.

    abstract:PURPOSE OF REVIEW:The purpose of this review is to explore the role of monocyte chemoattractant protein-1 (MCP-1 or CCL2) in the processes that underpin bone remodelling, particularly the action of osteoblasts and osteoclasts, and its role in the development and metastasis of cancers that target the bone. RECENT FINDI...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-019-00545-7

    authors: Mulholland BS,Forwood MR,Morrison NA

    更新日期:2019-12-01 00:00:00

  • Biologicals in osteoporosis: teriparatide and parathyroid hormone in women and men.

    abstract::Osteoporosis is characterized by the occurrence of a host of fractures. According to densitometric values, an operational definition for osteoporosis corresponds to a loss of 25% to 30% (-2.5 T-scores) compared with the mean values of bone mineral density of young premenopausal women. For years, research tried to deve...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章

    doi:10.1007/s11914-010-0024-1

    authors: Devogelaer JP,Boutsen Y,Manicourt DH

    更新日期:2010-09-01 00:00:00

  • Endocrine crosstalk between muscle and bone.

    abstract::The musculoskeletal system is a complex organ comprised of the skeletal bones, skeletal muscles, tendons, ligaments, cartilage, joints, and other connective tissue that physically and mechanically interact to provide animals and humans with the essential ability of locomotion. This mechanical interaction is undoubtedl...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-014-0209-0

    authors: Brotto M,Johnson ML

    更新日期:2014-06-01 00:00:00

  • Timing of subsequent fractures after an initial fracture.

    abstract::A prior fracture is a well-documented risk factor for a subsequent fracture and it doubles the risk of subsequent fractures. Few studies have investigated the time that elapses between the initial and subsequent fracture. These studies show that the subsequent fracture risk is not constant, but fluctuates over time. T...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-010-0023-2

    authors: van Geel TA,Huntjens KM,van den Bergh JP,Dinant GJ,Geusens PP

    更新日期:2010-09-01 00:00:00

  • Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures.

    abstract:PURPOSE OF REVIEW:To summarize reports published since the 2013 American Society of Bone and Mineral Research Task Force Report on atypical femoral fractures (AFF). RECENT FINDINGS:The absolute incidence of AFFs remains low. AFFs are primarily associated with prolonged bisphosphonate (BP) exposure, but have also been ...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-018-0464-6

    authors: Starr J,Tay YKD,Shane E

    更新日期:2018-08-01 00:00:00

  • Anorexia, bulimia, and the athletic triad: evaluation and management.

    abstract::Caloric restriction caused by undernutrition or over-exercise is increasingly common and has significant health consequences such as hypothalamic amenorrhea, infertility, attainment of low peak bone mass, and bone loss leading to fracture. In these patients, the pathophysiology of amenorrhea and bone loss is multifact...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-007-0011-3

    authors: Fenichel RM,Warren MP

    更新日期:2007-12-01 00:00:00

  • In Vivo Osteocyte Mechanotransduction: Recent Developments and Future Directions.

    abstract:PURPOSE OF REVIEW:Mechanical loading is an essential stimulus for skeletal tissues. Osteocytes are primarily responsible for sensing mechanical stimuli in bone and for orchestrating subsequent responses. This is critical for maintaining homeostasis, and responding to injury/disease. The osteocyte mechanotransduction pa...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-018-0485-1

    authors: Hinton PV,Rackard SM,Kennedy OD

    更新日期:2018-12-01 00:00:00

  • Commentary: the five Ws of a Fracture Liaison Service: why, who, what, where, and how? In osteoporosis, we reap what we sow.

    abstract::Establishing a Fracture Liaison Service (FLS) to identify and treat patients with a recent fragility fracture has been shown to be effective, save money, useful to document high quality of care, and makes good clinical sense. A FLS starts with an osteoporosis champion and encompasses identification of patients with a ...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章

    doi:10.1007/s11914-013-0177-9

    authors: Curtis JR,Silverman SL

    更新日期:2013-12-01 00:00:00

  • Is it ethical to use placebos in osteoporosis clinical trials?

    abstract::Because there are now effective agents for treatment of osteoporosis, the question is being raised as to whether or not it is ethical to have placebo-controlled trials of new agents. It is ethical for patients who are at low risk of serious or irreversible harm to participate in placebo-controlled trials as long as th...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-004-0012-4

    authors: Watts NB

    更新日期:2004-03-01 00:00:00

  • microRNA Regulation of Skeletal Development.

    abstract:PURPOSE OF REVIEW:Osteogenesis is a complex process involving the specification of multiple progenitor cells and their maturation and differentiation into matrix-secreting osteoblasts. Osteogenesis occurs not only during embryogenesis but also during growth, after an injury, and in normal homeostatic maintenance. While...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-017-0379-7

    authors: Sera SR,Zur Nieden NI

    更新日期:2017-08-01 00:00:00

  • Diabetes and Bone Marrow Adiposity.

    abstract:PURPOSE OF REVIEW:This study aims to describe bone marrow fat changes in diabetes and to discuss the potential role of marrow fat in skeletal fragility. RECENT FINDINGS:Advances in non-invasive imaging have facilitated marrow fat research in humans. In contrast to animal studies which clearly demonstrate higher levels...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-016-0336-x

    authors: Kim TY,Schafer AL

    更新日期:2016-12-01 00:00:00

  • Epidemiology and pathophysiology of osteoporosis in men.

    abstract::Osteoporosis in men is an unrecognized but growing problem as the number of men who live to old age increases. The 10-year fracture risk at age 50 quadruples by age 80, and in general the incidence rate of osteoporotic fracture in men is about half that of women. Of note, the mortality and morbidity after hip fracture...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-996-0030-5

    authors: Adler RA

    更新日期:2006-09-01 00:00:00

  • Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

    abstract::Metabolic bone disease is a major public health concern, especially when it manifests as hip fracture which carries significant morbidity and mortality. Individuals with neurological disease are at higher risk of osteopenia, osteoporosis and fragility fracture compared to age-matched controls, yet this is under-apprec...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-016-0320-5

    authors: Binks S,Dobson R

    更新日期:2016-10-01 00:00:00

  • Can physical activity improve peak bone mass?

    abstract::The pediatric origin of osteoporosis has led many investigators to focus on determining factors that influence bone gain during growth and methods for optimizing this gain. Bone responds to bone loading activities by increasing mass or size. Overall, pediatric studies have found a positive effect of bone loading on bo...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-013-0152-5

    authors: Specker B,Minett M

    更新日期:2013-09-01 00:00:00

  • Glucocorticoid-Induced Osteoporosis: New Insights into the Pathophysiology and Treatments.

    abstract:PURPOSE OF THIS REVIEW:The goal of the review is to provide an updated understanding of the pathophysiology of glucocorticoid-induced osteoporosis and treatment recommendations. RECENT FINDINGS:Glucocorticoids reduce osteoblast and osteocyte lifespan and activity and reduce the vascularity of the bone that together ma...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-019-00498-x

    authors: Lane NE

    更新日期:2019-02-01 00:00:00

  • Therapies for musculoskeletal disease: can we treat two birds with one stone?

    abstract::Musculoskeletal diseases are highly prevalent with staggering annual health care costs across the globe. The combined wasting of muscle (sarcopenia) and bone (osteoporosis)-both in normal aging and pathologic states-can lead to vastly compounded risk for fracture in patients. Until now, our therapeutic approach to the...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-014-0204-5

    authors: Girgis CM,Mokbel N,Digirolamo DJ

    更新日期:2014-06-01 00:00:00

  • New Insights in Understanding and Treating Bone Fracture Pain.

    abstract:PURPOSE OF REVIEW:This paper describes recent advances in understanding the mechanisms that drive fracture pain and how these findings are helping develop new therapies to treat fracture pain. RECENT FINDINGS:Immediately following fracture, mechanosensitive nerve fibers that innervate bone are mechanically distorted. ...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-018-0446-8

    authors: Mitchell SAT,Majuta LA,Mantyh PW

    更新日期:2018-08-01 00:00:00

  • Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction.

    abstract::Surrogate markers in clinical medicine provide a useful means to assess therapeutic response to pharmacologic therapy in a wide range of chronic disease states. In the area of osteoporosis, the surrogate markers of change in bone mineral density (BMD) and bone turnover markers (BTM) provide the clinician with a means ...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-005-0018-6

    authors: Miller PD

    更新日期:2005-09-01 00:00:00

  • The biology of osteocytes.

    abstract::Osteocytes, the most abundant cell type in bone, remain the least characterized. Several theories have been proposed regarding their function, including osteolysis, sensing the strains produced in response to mechanical loading of bones, and producing signals that affect the function of osteoblasts and osteoclasts and...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-007-0007-z

    authors: Kogianni G,Noble BS

    更新日期:2007-06-01 00:00:00

  • Osteoporosis treatment by a new active vitamin D3 compound, eldecalcitol, in Japan.

    abstract::Although vitamin D is used mainly as a nutritional supplement in osteoporosis treatment, its active form, 1,25-dihydroxyvitamin D [1,25(OH)(2)D], has an effect to maintain bone remodeling balance as well. Eldecalcitol is an analog of 1,25(OH) (2)D(3) with stronger effects than its native form in improving bone remodel...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章

    doi:10.1007/s11914-012-0116-1

    authors: Matsumoto T

    更新日期:2012-12-01 00:00:00

  • Calcium supplementation: is protecting against osteoporosis counter to protecting against cardiovascular disease?

    abstract::Calcium is the dominant mineral in bone and is a shortfall nutrient in the diet. For those consuming inadequate dietary calcium, calcium supplements have been a standard strategy for prevention of osteoporosis. Recently, calcium supplementation has been linked to both increased and decreased cardiovascular disease ris...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-014-0208-1

    authors: Weaver CM

    更新日期:2014-06-01 00:00:00

  • Altered Central Sensitization and Pain Modulation in the CNS in Chronic Joint Pain.

    abstract::Musculoskeletal pain disorders are the second largest contributor to global disability underlining the significance of effective treatments. However, treating chronic musculoskeletal pain, and chronic joint pain (osteoarthritis (OA)) in particular, is challenging as the underlying peripheral and central pain mechanism...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-015-0276-x

    authors: Arendt-Nielsen L,Skou ST,Nielsen TA,Petersen KK

    更新日期:2015-08-01 00:00:00

  • Romosozumab: a Review of Efficacy, Safety, and Cardiovascular Risk.

    abstract:PURPOSE OF REVIEW:Authors review the safety and efficacy of romosozumab for the treatment of osteoporosis as demonstrated in three phase III clinical trials and offer insights into the potential cardiovascular risk associated with its use. RECENT FINDINGS:Incidence of new vertebral fracture is dramatically reduced wit...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-020-00652-w

    authors: Fixen C,Tunoa J

    更新日期:2021-01-07 00:00:00

  • Ex vivo Bone Models and Their Potential in Preclinical Evaluation.

    abstract:PURPOSE OF REVIEW:Novel therapies for damaged and diseased bone are being developed in a preclinical testing process consisting of in vitro cell experiments followed by in vivo animal studies. The in vitro results are often not representative of the results observed in vivo. This could be caused by the complexity of th...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-020-00649-5

    authors: Cramer EEA,Ito K,Hofmann S

    更新日期:2021-01-11 00:00:00

  • Intercellular cross-talk among bone cells: new factors and pathways.

    abstract::Intercellular communication within the bone microenvironment is critical for the maintenance of normal bone structure. Osteoblast-lineage cells at all stages of differentiation, from pluripotent precursors to matrix-embedded osteocytes, produce regulatory factors that modulate the differentiation and activity of both ...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-012-0096-1

    authors: Sims NA,Walsh NC

    更新日期:2012-06-01 00:00:00

  • Cellular Processes by Which Osteoblasts and Osteocytes Control Bone Mineral Deposition and Maturation Revealed by Stage-Specific EphrinB2 Knockdown.

    abstract:PURPOSE OF REVIEW:We outline the diverse processes contributing to bone mineralization and bone matrix maturation by describing two mouse models with bone strength defects caused by restricted deletion of the receptor tyrosine kinase ligand EphrinB2. RECENT FINDINGS:Stage-specific EphrinB2 deletion differs in its effe...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-019-00524-y

    authors: Blank M,Sims NA

    更新日期:2019-10-01 00:00:00

  • Potential Importance of Immune System Response to Exercise on Aging Muscle and Bone.

    abstract:PURPOSE OF REVIEW:The age-related loss of skeletal muscle and bone tissue decreases functionality and increases the risk for falls and injuries. One contributing factor of muscle and bone loss over time is chronic low-grade inflammation. Exercise training is an effective countermeasure for decreasing the loss of muscle...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-020-00596-1

    authors: Cornish SM,Chilibeck PD,Candow DG

    更新日期:2020-08-01 00:00:00

  • Inherited Arterial Calcification Syndromes: Etiologies and Treatment Concepts.

    abstract:PURPOSE OF REVIEW:We give an update on the etiology and potential treatment options of rare inherited monogenic disorders associated with arterial calcification and calcific cardiac valve disease. RECENT FINDINGS:Genetic studies of rare inherited syndromes have identified key regulators of ectopic calcification. Based...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-017-0370-3

    authors: Nitschke Y,Rutsch F

    更新日期:2017-08-01 00:00:00